Michael S. Perry, Director at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 11,600 shares at $87.30 ($1.0M) on 2026-08-18, disclosed to the SEC on 2026-08-20.
Open-market sale of $1.0M ARWR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RCEL | SELL | 2022-02-25 | $189K | — | Filing → |
| ARWR | SELL | 2022-01-04 | $460K | — | Filing → |
| RCEL | SELL | 2021-09-07 | $464K | — | Filing → |